Target intelligence / Profile preview

Urothelium (Bladder epithelium)

Molecular classification
Other
01

Overview

The bladder epithelium, or urothelium, is a specialized stratified tissue that lines the urinary bladder and serves as a critical interface between the urine and the underlying tissues. Its primary biological function is to act as a highly impermeable barrier, known as the blood-urine barrier, which prevents the reabsorption of toxic metabolites and electrolytes while allowing the bladder to expand and contract (StatPearls, 2023). In disease states, the urothelium is the primary site for the development of urothelial carcinoma and plays a central role in the pathogenesis of interstitial cystitis and recurrent urinary tract infections (NIH, 2021). While the urothelium is a tissue rather than a single molecular target, it is the focus of intravesical therapies where drugs like BCG or mitomycin are delivered directly into the bladder lumen to treat superficial tumors (PubMed, 2022). Additionally, the urothelium expresses various receptors and ion channels, such as P2X3 and TRPV1, which are increasingly recognized as specific molecular targets for managing bladder hypersensitivity and overactive bladder (Nature Reviews Urology, 2019). Understanding the urothelium's barrier and signaling properties is essential for developing targeted treatments for lower urinary tract disorders.

Other names
Bladder epitheliumTransitional epitheliumUroepitheliumUrinary bladder mucosa
02

Mechanism of action

Therapeutic agents interact with the bladder epithelium through intravesical delivery to induce local immune responses, exert direct cytotoxic effects on malignant cells, or restore the protective glycosaminoglycan layer to reduce permeability.

03

Biological functions

Barrier functionSignal transductionCell signalingOsmoregulation
04

Disease associations

Bladder cancerInterstitial cystitisUrinary tract infectionOveractive bladder
05

Safety considerations

Chemical cystitisSystemic absorption and toxicityUrothelial irritationHematuriaUrinary frequency
06

Interacting drugs

Bacillus Calmette-Guerin (BCG)

5 more in the full profile.

07

Biomarkers

Uroplakin 1A (UPK1A)Uroplakin 2 (UPK2)Uroplakin 3A (UPK3A)Cytokeratin 7 (CK7)Cytokeratin 20 (CK20)

Beyond the preview

Go deeper on Urothelium (Bladder epithelium).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Urothelium (Bladder epithelium).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call